Warrior Met Coal Inc (NYSE:HCC) – Equities research analysts at Jefferies Financial Group reduced their FY2019 earnings per share (EPS) estimates for shares of Warrior Met Coal in a report issued on Wednesday, December 11th, according to Zacks Investment Research. Jefferies Financial Group analyst C. Lafemina now forecasts that the company will earn $5.85 per share for the year, down from their prior forecast of $5.95. Jefferies Financial Group also issued estimates for Warrior Met Coal’s FY2021 earnings at $4.04 EPS.

Accenture Plc (NYSE:ACN) – Equities researchers at KeyCorp upped their Q3 2020 earnings estimates for Accenture in a note issued to investors on Monday, December 16th, Zacks Investment Research reports. KeyCorp analyst A. Ramnani now anticipates that the information technology services provider will post earnings of $2.10 per share for the quarter, up from their previous forecast of $2.07. KeyCorp currently has a “Overweight” rating and a $219.00 target price on the stock.

AGCO Co. (NYSE:AGCO) – Stock analysts at Jefferies Financial Group reduced their FY2021 earnings per share (EPS) estimates for shares of AGCO in a research report issued on Monday, December 16th, according to Zacks Investment Research. Jefferies Financial Group analyst S. Volkmann now expects that the industrial products company will earn $5.90 per share for the year, down from their prior forecast of $6.50.

EXACT Sciences Co. (NASDAQ:EXAS) – Dougherty & Co issued their FY2019 EPS estimates for shares of EXACT Sciences in a research note issued on Monday, December 16th, according to Zacks Investment Research. Dougherty & Co analyst K. Bauser expects that the medical research company will earn ($1.59) per share for the year. Dougherty & Co has a “Buy” rating and a $120.00 price objective on the stock. Dougherty & Co also issued estimates for EXACT Sciences’ Q4 2019 earnings at ($0.33) EPS and FY2020 earnings at ($0.33) EPS.

OncoSec Medical Inc (NASDAQ:ONCS) – Equities research analysts at Piper Jaffray Companies lowered their Q2 2020 earnings per share estimates for OncoSec Medical in a report released on Monday, December 16th, Zacks Investment Research reports. Piper Jaffray Companies analyst E. Tenthoff now anticipates that the biotechnology company will post earnings per share of ($0.91) for the quarter, down from their prior estimate of ($0.79). Piper Jaffray Companies also issued estimates for OncoSec Medical’s Q3 2020 earnings at ($0.76) EPS, FY2020 earnings at ($3.39) EPS, Q1 2021 earnings at ($0.81) EPS, Q2 2021 earnings at ($0.86) EPS, Q3 2021 earnings at ($0.88) EPS, Q4 2021 earnings at ($0.93) EPS and FY2021 earnings at ($3.48) EPS.

Cloudera Inc (NYSE:CLDR) – Analysts at DA Davidson boosted their FY2020 EPS estimates for shares of Cloudera in a research note issued to investors on Monday, December 9th, Zacks Investment Research reports. DA Davidson analyst R. Jaluria now expects that the company will post earnings of ($0.99) per share for the year, up from their prior forecast of ($1.04). DA Davidson has a “Buy” rating and a $13.00 price objective on the stock. DA Davidson also issued estimates for Cloudera’s Q4 2020 earnings at ($0.22) EPS and FY2021 earnings at ($0.91) EPS.

Ulta Beauty Inc (NASDAQ:ULTA) – Equities research analysts at Piper Jaffray Companies dropped their Q4 2020 earnings per share (EPS) estimates for Ulta Beauty in a research note issued on Thursday, December 5th, according to Zacks Investment Research. Piper Jaffray Companies analyst E. Murphy now forecasts that the specialty retailer will post earnings of $3.66 per share for the quarter, down from their previous estimate of $3.69. Piper Jaffray Companies has a “Neutral” rating and a $228.00 price objective on the stock. Piper Jaffray Companies also issued estimates for Ulta Beauty’s Q4 2021 earnings at $4.06 EPS, Q1 2022 earnings at $3.61 EPS, Q2 2022 earnings at $3.35 EPS and Q3 2022 earnings at $2.78 EPS.

Tiffany & Co. (NYSE:TIF) – Equities research analysts at Oppenheimer decreased their FY2020 earnings per share estimates for shares of Tiffany & Co. in a research report issued to clients and investors on Thursday, December 5th, Zacks Investment Research reports. Oppenheimer analyst B. Nagel now forecasts that the specialty retailer will earn $4.41 per share for the year, down from their prior estimate of $4.69. Oppenheimer has a “Market Perform” rating on the stock. Oppenheimer also issued estimates for Tiffany & Co.’s Q4 2020 earnings at $1.61 EPS, Q1 2021 earnings at $1.06 EPS, Q2 2021 earnings at $1.16 EPS, Q3 2021 earnings at $0.71 EPS, Q4 2021 earnings at $1.69 EPS, FY2021 earnings at $4.63 EPS and FY2022 earnings at $5.00 EPS.

Diamondback Energy Inc (NASDAQ:FANG) – Investment analysts at Capital One Financial cut their FY2019 earnings estimates for Diamondback Energy in a report issued on Monday, December 9th, Zacks Investment Research reports. Capital One Financial analyst R. Tullis now expects that the oil and natural gas company will post earnings of $6.48 per share for the year, down from their previous forecast of $6.60. Capital One Financial also issued estimates for Diamondback Energy’s Q4 2019 earnings at $1.93 EPS.

Workday Inc (NASDAQ:WDAY) – Equities research analysts at Jefferies Financial Group issued their Q1 2022 EPS estimates for Workday in a research report issued on Wednesday, December 4th, according to Zacks Investment Research. Jefferies Financial Group analyst B. Thill expects that the software maker will post earnings per share of ($0.37) for the quarter. Jefferies Financial Group currently has a “Hold” rating and a $188.00 price target on the stock. Jefferies Financial Group also issued estimates for Workday’s Q2 2022 earnings at ($0.37) EPS and Q3 2022 earnings at ($0.33) EPS.